Galectin Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Galectin Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Galectin Therapeutics Inc
Rating: 0.97950
Author: Trendlyne DVM scores

about

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...

3.11 -0.05 (-1.58%)

56.38% Fall from 52W High

161.6K

XNAS Volume

XNAS 13 Mar, 2026 1:33 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

39.2 / 100

No estimates available

Galectin Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Galectin Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...

56.38% Fall from 52W High

SWOT Analysis

Galectin Therapeutics Inc Live Price Chart